Described are novel salts of the compound (3R,4R,5S)-5-(difluoromethyl) piperidine-3,4-diol (formula I), as well as methods of using the same for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system. Exemplified salts include a fumerate salt and a tosylate salt. In particular, the present disclosure provides methods for preventing and/or treating Gaucher’s disease and/or Parkinson’s disease.